GIO Therapeutics AG

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

Ultimate Medicine AG, a Swiss preclinical pharmaceutical company, is developing an innovative oral treatment for age-related cognitive disorders. Our approach targets an overlooked pathway complementing standard amyloid-β/tau therapies.

TheraPPI Bioscience, a preclinical biotechnology company developing small molecules modifying protein interactions in oncology, rare diseases and inflammation